Search

everythinglearnresearchcommunity

for

Search:↓

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

Scalp photography helps patients feel less anxious about hair loss, agree more with doctors on severity, and stay motivated for treatment.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Trichoscopy is a key method for dermatologists to quickly and effectively diagnose hair and scalp conditions.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

NLCs with manual massage greatly improve clobetasol delivery to hair follicles.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

EVG staining is the most reliable method for diagnosing alopecia.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

White and yellow dots indicate severe female hair loss in dark skin.

Two mouse mutations cause similar hair loss despite different skin changes.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

Hair follicle systems are being engineered to better mimic natural hair follicles for studying hair disorders and testing treatments.

Hair transplantation is a surgical procedure to move hair to bald areas, requires good donor hair, and results show in about a year.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Hair restoration techniques and new cell sources improve hair loss treatments.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Different hair loss types need accurate diagnosis for proper treatment.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.